Matrix Capital Management Company, LP's Form 4 filing
Zentalis Pharmaceuticals, Inc. (ZNTL) · filed Jun 20, 2023
- Accession no.
- 0000902664-23-003642
- Filed
- Jun 20, 2023, 4:30 PM ET
- Trade date
- Jun 20, 2023
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $107.9M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Matrix Capital Management Company, LPCIK 0001410830 | 10% Owner |
| Goel David E.CIK 0001548144 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 20, 2023 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +4,760,000 | $22.66 | +$107,861,600 | 13,959,973 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.